Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the ...

Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Eli Lilly's 3-year historical return on invested capital (without goodwill) is 38.6%, which is above the estimate of its cost of capital of 10.4%. As such, we assign the firm a ValueCreation ...

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.

We are increasing Eli Lilly’s fair value estimate to $500 from $450 following solid fourth-quarter results with robust sales from diabetes drug Mounjaro and strong pipeline advancements running ...

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline By Angelica Peebles,CNBC • Published October 2, 2024 • Updated on October 2, 2024 at 10:55 am ...